Stockscreener 앱 받기
3.04%
Amgen Inc 주식(AMGN)의 최신 뉴스
Amgen Inc. (NASDAQ:AMGN) Plans Quarterly Dividend of $2.52 - MarketBeat
Amgen: Wait For A Better Entry Point (Rating Downgrade) (NASDAQ:AMGN) - Seeking Alpha
ARK Investment Management LLC Sells 10,668 Shares of Amgen Inc. $AMGN - MarketBeat
Cytokines Market Global Forecast 2026-2032: Precise Treatments, Strategic Partnerships, and Supply Chain Resilience Fueling the $95+ Billion Market - GlobeNewswire Inc.
CI Investments Inc. Has $6.34 Million Stock Position in Amgen Inc. $AMGN - MarketBeat
Is Amgen (AMGN) Pricing Reflect Its Recent 24% One Year Share Price Return - Yahoo! Finance Canada
Amgen (AMGN) Maintains Quarterly Dividend of $2.52 Per Share - GuruFocus
Amgen Keeps Quarterly Dividend at $2.52 a Share, Payable June 5 to Holders of Record May 15 - marketscreener.com
AMGEN ANNOUNCES 2026 SECOND QUARTER DIVIDEND - Amgen
Amgen announces 2026 second quarter dividend - marketscreener.com
Amgen Advances Blinatumomab Franchise With New Phase 3 Subcutaneous Trial - TipRanks
Dimensional Fund Advisors Boosts Amgen Holdings - National Today
Smith Chas P & Associates PA Cpas Sells 47,455 Shares of Amgen Inc. $AMGN - MarketBeat
Amgen Inc. $AMGN Shares Sold by Victory Capital Management Inc. - MarketBeat
Mcdonald Partners LLC Decreases Holdings in Amgen Inc. $AMGN - MarketBeat
GLP-1 Receptor Agonist Business Analysis Report 2026: Market to Reach $137.4 Billion by 2030 - GlobeNewswire Inc.
Dimensional Fund Advisors LP Raises Holdings in Amgen Inc. $AMGN - MarketBeat
Is It Time To Reassess Amgen (AMGN) After Its Strong Multi Year Share Price Run? - simplywall.st
AMGN Financials: Income Statement, Balance Sheet & Cash Flow - Stock Titan
Amgen Inc. (AMGN) is Drawing Interest from Investors: Key Information You Need to Know - Bitget
Amgen EVP Sold $20.77M In Company Stock - Benzinga
Amgen Inc. (AMGN) is Attracting Investor Attention: Here is What You Should Know - Yahoo Finance Singapore
Amgen stock forecast for 2030: $6B patent exposure challenges $500 level - Traders Union
Fisher Asset Management LLC Acquires 375,463 Shares of Amgen Inc. $AMGN - MarketBeat
IBRX Stock Extends Rally To Day 3: Founder Drops ‘Prelude’ To 2025 Earnings, Slams Bristol Myers, Amgen Cancer Playbook - Stocktwits
Amgen (NASDAQ:AMGN) Sets New 1-Year HighShould You Buy? - MarketBeat
Amgen (NASDAQ:AMGN) Hits Annual High Within The Nasdaq 100 Index Rally - Kalkine Media
Amgen Touts Broad Portfolio Momentum, MariTide Milestones and Repatha Access Push at TD Cowen Conf - Yahoo Finance
Amgen Inc. Shs Sponsored Canadian Depository Receipt Hedged Reg S Revenue Breakdown – NEO:AMGN - TradingView
How North Carolina Attracted Amgen and Roche To Become a Next-Gen Obesity Drug Production Hotspot - BioSpace
Amgen (AMGN) EVP Esteban Santos exercises options and sells 54,792 shares - Stock Titan
Amgen at TD Cowen Conference: Strategic Growth and Challenges - Investing.com India
Amgen Is Up 35% in the Last 6 Months. Here’s Where the Stock Could Go in 2026 - TIKR.com
Amgen’s Phase 3 Gout Trial Pits Subcutaneous Pegloticase Against IV Dosing - TipRanks
Amgen Inc. (AMGN) Stock Report: Evaluating the 106% Return on Equity and Market Prospects - DirectorsTalk Interviews
Laurel Wealth Advisors LLC Cuts Position in Amgen Inc. $AMGN - MarketBeat
Bahl & Gaynor Inc. Lowers Stock Holdings in Amgen Inc. $AMGN - MarketBeat
6,843 Shares in Amgen Inc. $AMGN Purchased by 111 Capital - MarketBeat
Amgen Deployed a Record $7.2 Billion in R&D: Here’s What Investors Should Expect - TIKR.com
How Amgen’s $4 Billion Long-Dated Bond Issuance At Amgen (AMGN) Has Changed Its Investment Story - Yahoo Finance
Amgen Recasts Growth Story With Product Momentum And Long Dated Funding - simplywall.st
Amgen Inc. (AMGN): A Bull Case Theory - Insider Monkey
Andra AP fonden Boosts Stake in Amgen - National Today
Harvest Portfolios Group Inc. Boosts Holdings in Amgen Inc. $AMGN - MarketBeat
Argent Trust Co Lowers Stock Holdings in Amgen Inc. $AMGN - MarketBeat
Andra AP fonden Raises Stake in Amgen Inc. $AMGN - MarketBeat
Amgen Inc. $AMGN Stock Holdings Boosted by Allianz SE - MarketBeat
Amgen Inc. stock outperforms competitors on strong trading day - MarketWatch
Insider plans sale of 54,792 AMGN shares (NASDAQ: AMGN) - Stock Titan
Amgen Advances Maridebart Cafraglutide Toward Mid-Stage Obesity and Liver Fat Trial - TipRanks
Amgen Fine-Tunes Evolocumab: New Bioavailability Study Signals Long-Term Cholesterol Franchise Focus - TipRanks
Amgen Nears a Nivolumab Biosimilar Milestone in Melanoma: What Investors Should Watch - TipRanks
Amgen Inc. $AMGN Shares Purchased by Sumitomo Mitsui Financial Group Inc. - MarketBeat
Handelsbanken Fonder AB Sells 47,932 Shares of Amgen Inc. $AMGN - MarketBeat
Intech Investment Management LLC Has $13.65 Million Position in Amgen Inc. $AMGN - MarketBeat
Erste Asset Management GmbH Decreases Position in Amgen Inc. $AMGN - MarketBeat
Empirical Asset Management LLC Has $306,000 Position in Amgen Inc. $AMGN - MarketBeat
P/E Ratio Insights for Amgen - Sahm
US Bancorp DE Has $194 Million Holdings in Amgen Inc. $AMGN - MarketBeat
Mitsubishi UFJ Asset Management Co. Ltd. Boosts Stock Position in Amgen Inc. $AMGN - MarketBeat
Primecap Management Co. CA Decreases Stock Position in Amgen Inc. $AMGN - MarketBeat
TD Asset Management Inc Has $108.85 Million Stock Holdings in Amgen Inc. $AMGN - MarketBeat
Amgen (NASDAQ:AMGN) Sets New 52-Week HighHere's What Happened - MarketBeat
Amgen stock hits all-time high at 385.63 USD - Investing.com South Africa
0.88%
0.36%
자본화:
|
볼륨(24시간):